{"transactions":[{"id":712513,"issuer":{"id":4487,"kind":"organization","name":"Xencor Inc"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-08T22:53:57.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":20604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal monthly installments over one year beginning on the one-month anniversary of June 16, 2026, such that the total number of shares will be fully vested on June 16, 2027."}],"balance_after":20604,"derivative":{"exercise_price":12.2,"expiration_date":"2036-06-15","underlying":"Common Stock","underlying_shares":20604},"source":{"system":"sec-edgar","filing":"0001313936-26-000004","document":"wk-form4_1783551235.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1313936/000131393626000004/wk-form4_1783551235.xml","form_type":"4"}},{"id":712512,"issuer":{"id":4487,"kind":"organization","name":"Xencor Inc"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-08T22:53:57.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":10302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that shall fully vest on the first anniversary of the date of grant."}],"balance_after":25849,"source":{"system":"sec-edgar","filing":"0001313936-26-000004","document":"wk-form4_1783551235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1313936/000131393626000004/wk-form4_1783551235.xml","form_type":"4"}},{"id":733612,"issuer":{"id":4487,"kind":"organization","name":"Xencor Inc"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-17T20:01:10.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":5064,"price":12.31,"value":62337.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a 10b5-1 plan adopted by the Reporting Person on March 4, 2026."}],"balance_after":15547,"source":{"system":"sec-edgar","filing":"0001313936-26-000002","document":"wk-form4_1781726467.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1313936/000131393626000002/wk-form4_1781726467.xml","form_type":"4"}},{"id":1109560,"issuer":{"id":4487,"kind":"organization","name":"Xencor Inc"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-16T23:35:14.000Z","date":"2025-06-12","kind":"grant","planned":true,"acquired":true,"shares":27372,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option will vest in equal monthly installments over one year beginning on the one-month anniversary of June 12, 2025, such that the total number of shares will be fully vested on June 12, 2026."}],"balance_after":27372,"derivative":{"exercise_price":9.43,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":27372},"source":{"system":"sec-edgar","filing":"0001127602-25-017604","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1313936/000112760225017604/form4.xml","form_type":"4"}},{"id":1109559,"issuer":{"id":4487,"kind":"organization","name":"Xencor Inc"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-16T23:35:14.000Z","date":"2025-06-16","kind":"sale","planned":true,"acquired":false,"shares":2215,"price":9.22,"value":20422.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a 10b5-1 plan adopted by the Reporting Person on June 28, 2024."}],"balance_after":20611,"source":{"system":"sec-edgar","filing":"0001127602-25-017604","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1313936/000112760225017604/form4.xml","form_type":"4"}},{"id":1109558,"issuer":{"id":4487,"kind":"organization","name":"Xencor Inc"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-16T23:35:14.000Z","date":"2025-06-12","kind":"grant","planned":true,"acquired":true,"shares":13686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that shall fully vest on the first anniversary of the date of grant."}],"balance_after":22826,"source":{"system":"sec-edgar","filing":"0001127602-25-017604","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1313936/000112760225017604/form4.xml","form_type":"4"}},{"id":1342686,"issuer":{"id":4487,"kind":"organization","name":"Xencor Inc"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-04T23:08:20.000Z","date":"2024-12-04","kind":"exercise","planned":true,"acquired":false,"shares":430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a 10b5-1 plan adopted by the Reporting Person on June 28, 2024."}],"balance_after":2062,"derivative":{"exercise_price":20,"exercise_date":"2016-06-09","expiration_date":"2025-06-08","underlying":"Common Stock","underlying_shares":430},"source":{"system":"sec-edgar","filing":"0001127602-24-028676","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1313936/000112760224028676/form4.xml","form_type":"4"}},{"id":1342685,"issuer":{"id":4487,"kind":"organization","name":"Xencor Inc"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-04T23:08:20.000Z","date":"2024-12-04","kind":"exercise","planned":true,"acquired":false,"shares":991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a 10b5-1 plan adopted by the Reporting Person on June 28, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/3 of the shares subject to the stock option vested and became exercisable on March 18, 2016, and the remaining shares vested in equal monthly installments over the subsequent 24 months."}],"balance_after":5716,"derivative":{"exercise_price":15.35,"expiration_date":"2025-03-17","underlying":"Common Stock","underlying_shares":991},"source":{"system":"sec-edgar","filing":"0001127602-24-028676","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1313936/000112760224028676/form4.xml","form_type":"4"}},{"id":1342684,"issuer":{"id":4487,"kind":"organization","name":"Xencor Inc"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-04T23:08:20.000Z","date":"2024-12-02","kind":"exercise","planned":true,"acquired":false,"shares":8293,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a 10b5-1 plan adopted by the Reporting Person on June 28, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/3 of the shares subject to the stock option vested and became exercisable on March 18, 2016, and the remaining shares vested in equal monthly installments over the subsequent 24 months."}],"balance_after":6707,"derivative":{"exercise_price":15.35,"expiration_date":"2025-03-17","underlying":"Common Stock","underlying_shares":8293},"source":{"system":"sec-edgar","filing":"0001127602-24-028676","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1313936/000112760224028676/form4.xml","form_type":"4"}},{"id":1342683,"issuer":{"id":4487,"kind":"organization","name":"Xencor Inc"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-04T23:08:20.000Z","date":"2024-12-02","kind":"exercise","planned":true,"acquired":false,"shares":5008,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a 10b5-1 plan adopted by the Reporting Person on June 28, 2024."}],"balance_after":2492,"derivative":{"exercise_price":20,"exercise_date":"2016-06-09","expiration_date":"2025-06-08","underlying":"Common Stock","underlying_shares":5008},"source":{"system":"sec-edgar","filing":"0001127602-24-028676","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1313936/000112760224028676/form4.xml","form_type":"4"}},{"id":1342682,"issuer":{"id":4487,"kind":"organization","name":"Xencor Inc"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-12-04T23:08:20.000Z","date":"2024-12-04","kind":"sale","planned":true,"acquired":false,"shares":1421,"price":27.0276,"value":38406.2196,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a 10b5-1 plan adopted by the Reporting Person on June 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.13, inclusive. The Reporting Person undertakes\nto provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each\nseparate price within the ranges set forth in this footnote."}],"balance_after":9140,"source":{"system":"sec-edgar","filing":"0001127602-24-028676","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1313936/000112760224028676/form4.xml","form_type":"4"}},{"id":1342681,"issuer":{"id":4487,"kind":"organization","name":"Xencor Inc"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-12-04T23:08:20.000Z","date":"2024-12-04","kind":"exercise","planned":true,"acquired":true,"shares":430,"price":20,"value":8600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a 10b5-1 plan adopted by the Reporting Person on June 28, 2024."}],"balance_after":10561,"source":{"system":"sec-edgar","filing":"0001127602-24-028676","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1313936/000112760224028676/form4.xml","form_type":"4"}},{"id":1342680,"issuer":{"id":4487,"kind":"organization","name":"Xencor Inc"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-12-04T23:08:20.000Z","date":"2024-12-04","kind":"exercise","planned":true,"acquired":true,"shares":991,"price":15.35,"value":15211.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a 10b5-1 plan adopted by the Reporting Person on June 28, 2024."}],"balance_after":10131,"source":{"system":"sec-edgar","filing":"0001127602-24-028676","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1313936/000112760224028676/form4.xml","form_type":"4"}},{"id":1342679,"issuer":{"id":4487,"kind":"organization","name":"Xencor Inc"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-12-04T23:08:20.000Z","date":"2024-12-02","kind":"sale","planned":true,"acquired":false,"shares":13301,"price":27.0299,"value":359524.6999,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a 10b5-1 plan adopted by the Reporting Person on June 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.20, inclusive. The Reporting Person undertakes\nto provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each\nseparate price within the ranges set forth in this footnote."}],"balance_after":9140,"source":{"system":"sec-edgar","filing":"0001127602-24-028676","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1313936/000112760224028676/form4.xml","form_type":"4"}},{"id":1342678,"issuer":{"id":4487,"kind":"organization","name":"Xencor Inc"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-12-04T23:08:20.000Z","date":"2024-12-02","kind":"exercise","planned":true,"acquired":true,"shares":5008,"price":20,"value":100160.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a 10b5-1 plan adopted by the Reporting Person on June 28, 2024."}],"balance_after":22441,"source":{"system":"sec-edgar","filing":"0001127602-24-028676","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1313936/000112760224028676/form4.xml","form_type":"4"}},{"id":1342677,"issuer":{"id":4487,"kind":"organization","name":"Xencor Inc"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-12-04T23:08:20.000Z","date":"2024-12-02","kind":"exercise","planned":true,"acquired":true,"shares":8293,"price":15.35,"value":127297.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a 10b5-1 plan adopted by the Reporting Person on June 28, 2024."}],"balance_after":17433,"source":{"system":"sec-edgar","filing":"0001127602-24-028676","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1313936/000112760224028676/form4.xml","form_type":"4"}},{"id":1396600,"issuer":{"id":4487,"kind":"organization","name":"Xencor Inc"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-10-01T20:08:23.000Z","date":"2024-09-27","kind":"sale","planned":false,"acquired":false,"shares":1853,"price":20.68,"value":38320.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale was pursuant to a 10b5-1 plan arranged to cover withholding taxes upon vesting of restricted stock units."}],"balance_after":9140,"source":{"system":"sec-edgar","filing":"0001127602-24-024667","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1313936/000112760224024667/form4.xml","form_type":"4"}},{"id":1477011,"issuer":{"id":4487,"kind":"organization","name":"Xencor Inc"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-17T20:19:08.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":11971,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal monthly installments over one year beginning on the one-month anniversary of June 13, 2024, such that the total number of shares will be fully vested on June 13, 2025."}],"balance_after":11971,"derivative":{"exercise_price":21.31,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":11971},"source":{"system":"sec-edgar","filing":"0001127602-24-018825","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1313936/000112760224018825/form4.xml","form_type":"4"}},{"id":1477010,"issuer":{"id":4487,"kind":"organization","name":"Xencor Inc"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-17T20:19:08.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":5986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that shall fully vest on the first anniversary of the date of grant."}],"balance_after":10993,"source":{"system":"sec-edgar","filing":"0001127602-24-018825","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1313936/000112760224018825/form4.xml","form_type":"4"}},{"id":1846286,"issuer":{"id":4487,"kind":"organization","name":"Xencor Inc"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-22T21:51:41.000Z","date":"2023-06-20","kind":"grant","planned":false,"acquired":true,"shares":10013,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal monthly installments over one year beginning on the one-month anniversary of June 20, 2023, such that the total number of shares will be fully vested on June 20, 2024."}],"balance_after":10013,"derivative":{"exercise_price":26.19,"expiration_date":"2033-06-20","underlying":"Common Stock","underlying_shares":10013},"source":{"system":"sec-edgar","filing":"0001127602-23-019284","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1313936/000112760223019284/form4.xml","form_type":"4"}},{"id":1846285,"issuer":{"id":4487,"kind":"organization","name":"Xencor Inc"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-22T21:51:41.000Z","date":"2023-06-20","kind":"grant","planned":false,"acquired":true,"shares":5007,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that shall fully vest on the first anniversary of the date of grant."}],"balance_after":5007,"source":{"system":"sec-edgar","filing":"0001127602-23-019284","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1313936/000112760223019284/form4.xml","form_type":"4"}},{"id":2220963,"issuer":{"id":4487,"kind":"organization","name":"Xencor Inc"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-27T20:35:16.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":21412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over one year beginning on the one-month anniversary of June 23, 2022, such that the total number of shares will be fully vested on June 23, 2023."}],"balance_after":21412,"derivative":{"exercise_price":26.58,"expiration_date":"2032-06-23","underlying":"Common Stock","underlying_shares":21412},"source":{"system":"sec-edgar","filing":"0001127602-22-018158","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1313936/000112760222018158/form4.xml","form_type":"4"}},{"id":2654557,"issuer":{"id":4487,"kind":"organization","name":"Xencor Inc"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-26T00:01:32.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":9728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over one year beginning on the one-month anniversary of June 24, 2021, such that the total number of shares will be fully vested on June 24, 2022."}],"balance_after":9728,"derivative":{"exercise_price":36.01,"expiration_date":"2031-06-24","underlying":"Common Stock","underlying_shares":9728},"source":{"system":"sec-edgar","filing":"0001415889-21-003235","document":"form4-06252021_080639.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1313936/000141588921003235/form4-06252021_080639.xml","form_type":"4"}},{"id":2812151,"issuer":{"id":4487,"kind":"organization","name":"Xencor Inc"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-03-04T01:00:29.000Z","date":"2016-06-23","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The initial filing incorrectly listed the exercise price at $14.83 per share due to an administrative error."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the option vest on June 23, 2017."}],"balance_after":7500,"derivative":{"exercise_price":14.43,"expiration_date":"2026-06-22","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001415889-21-001294","document":"form4a-03032021_080308.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1313936/000141588921001294/form4a-03032021_080308.xml","form_type":"4/A","original_submission_date":"2016-07-08"}},{"id":3097426,"issuer":{"id":4487,"kind":"organization","name":"Xencor Inc"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-30T00:27:09.000Z","date":"2020-06-25","kind":"grant","acquired":true,"shares":13953,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over one year beginning on the one-month anniversary of June 25, 2020, such that the total number of shares will be fully vested on June 25, 2021."}],"balance_after":13953,"derivative":{"exercise_price":33.42,"expiration_date":"2030-06-24","underlying":"Common Stock","underlying_shares":13953},"source":{"system":"sec-edgar","filing":"0001209191-20-039290","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1313936/000120919120039290/doc4.xml","form_type":"4"}},{"id":3388599,"issuer":{"id":154258,"kind":"organization","name":"ALDER BIOPHARMACEUTICALS INC","symbol":"ALDR"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-24T18:58:45.000Z","date":"2019-10-22","kind":"disposition_to_issuer","acquired":false,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"On September 16, 2019, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Lundbeck, Lundbeck LLC and Purchaser.  On October 22, 2019 (the \"Effective Time\"), Purchaser merged with and into the Issuer pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Issuer being the surviving corporation and becoming a wholly-owned subsidiary of Lundbeck."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to this option, whether or not vested, were cancelled and converted into the right to receive both (i) a cash payment equal to (A) the excess, if any of (x) $18.00 over (y) the Exercise Price per share listed in Column 2 of Table II of this Form 4, multiplied by (B) the total number of shares listed in Column 5 of Table II of this Form 4, and (ii) one non-transferable contingent value right for each share subject to this option, which represents the contractual right to receive up to an additional $2.00 per share upon achievement of a milestone."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"The shares subject to this option shall fully vest and become exercisable on the date of the 2020 Annual Meeting of the Stockholders of the Issuer, so long as the Reporting Person provides continuous service to the Issuer through such date."}],"balance_after":0,"derivative":{"exercise_price":11.01,"expiration_date":"2029-05-22","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001209191-19-053913","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1423824/000120919119053913/doc4.xml","form_type":"4"}},{"id":3388598,"issuer":{"id":154258,"kind":"organization","name":"ALDER BIOPHARMACEUTICALS INC","symbol":"ALDR"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-24T18:58:45.000Z","date":"2019-10-22","kind":"disposition_to_issuer","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"On September 16, 2019, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Lundbeck, Lundbeck LLC and Purchaser.  On October 22, 2019 (the \"Effective Time\"), Purchaser merged with and into the Issuer pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Issuer being the surviving corporation and becoming a wholly-owned subsidiary of Lundbeck."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to this option, whether or not vested, were cancelled and converted into the right to receive both (i) a cash payment equal to (A) the excess, if any of (x) $18.00 over (y) the Exercise Price per share listed in Column 2 of Table II of this Form 4, multiplied by (B) the total number of shares listed in Column 5 of Table II of this Form 4, and (ii) one non-transferable contingent value right for each share subject to this option, which represents the contractual right to receive up to an additional $2.00 per share upon achievement of a milestone."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"The shares subject to this option shall fully vest and become exercisable on the date of the 2019 Annual Meeting of the Stockholders of the Issuer, so long as the Reporting Person provides continuous service to the Issuer through such date. The shares subject to this option are fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":15.5,"expiration_date":"2028-05-22","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-19-053913","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1423824/000120919119053913/doc4.xml","form_type":"4"}},{"id":3388597,"issuer":{"id":154258,"kind":"organization","name":"ALDER BIOPHARMACEUTICALS INC","symbol":"ALDR"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-24T18:58:45.000Z","date":"2019-10-22","kind":"disposition_to_issuer","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"On September 16, 2019, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Lundbeck, Lundbeck LLC and Purchaser.  On October 22, 2019 (the \"Effective Time\"), Purchaser merged with and into the Issuer pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Issuer being the surviving corporation and becoming a wholly-owned subsidiary of Lundbeck."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to this option, whether or not vested, were cancelled and converted into the right to receive both (i) a cash payment equal to (A) the excess, if any of (x) $18.00 over (y) the Exercise Price per share listed in Column 2 of Table II of this Form 4, multiplied by (B) the total number of shares listed in Column 5 of Table II of this Form 4, and (ii) one non-transferable contingent value right for each share subject to this option, which represents the contractual right to receive up to an additional $2.00 per share upon achievement of a milestone."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The shares subject to this option shall fully vest and become exercisable on the date of the 2018 Annual Meeting of the Stockholders of the Issuer, so long as the Reporting Person provides continuous service to the Issuer through such date. The shares subject to this option are fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":16.9,"expiration_date":"2027-05-23","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-19-053913","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1423824/000120919119053913/doc4.xml","form_type":"4"}},{"id":3388596,"issuer":{"id":154258,"kind":"organization","name":"ALDER BIOPHARMACEUTICALS INC","symbol":"ALDR"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-24T18:58:45.000Z","date":"2019-10-22","kind":"disposition_to_issuer","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"On September 16, 2019, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Lundbeck, Lundbeck LLC and Purchaser.  On October 22, 2019 (the \"Effective Time\"), Purchaser merged with and into the Issuer pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Issuer being the surviving corporation and becoming a wholly-owned subsidiary of Lundbeck."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The shares subject to this option, whether vested or not, were cancelled at the Effective Time without any consideration payable therefor."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The shares subject to this option shall fully vest and become exercisable on the date of the 2017 Annual Meeting of the Stockholders of the Issuer, so long as the Reporting Person provides continuous service to the Issuer through such date.  The shares subject to this option are fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":29.26,"expiration_date":"2026-05-25","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-19-053913","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1423824/000120919119053913/doc4.xml","form_type":"4"}},{"id":3388595,"issuer":{"id":154258,"kind":"organization","name":"ALDER BIOPHARMACEUTICALS INC","symbol":"ALDR"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-24T18:58:45.000Z","date":"2019-10-22","kind":"disposition_to_issuer","acquired":false,"shares":6350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"On September 16, 2019, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Lundbeck, Lundbeck LLC and Purchaser.  On October 22, 2019 (the \"Effective Time\"), Purchaser merged with and into the Issuer pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Issuer being the surviving corporation and becoming a wholly-owned subsidiary of Lundbeck."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The shares subject to this option shall fully vest and become exercisable on the date of the 2016 Annual Meeting of the Stockholders of the Issuer, so long as the Reporting Person provides continuous service to the Issuer through such date. The shares subject to this option are fully vested as of the date hereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The shares subject to this option, whether vested or not, were cancelled at the Effective Time without any consideration payable therefor."}],"balance_after":0,"derivative":{"exercise_price":39.66,"expiration_date":"2025-05-18","underlying":"Common Stock","underlying_shares":6350},"source":{"system":"sec-edgar","filing":"0001209191-19-053913","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1423824/000120919119053913/doc4.xml","form_type":"4"}},{"id":3388594,"issuer":{"id":154258,"kind":"organization","name":"ALDER BIOPHARMACEUTICALS INC","symbol":"ALDR"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-24T18:58:45.000Z","date":"2019-10-22","kind":"disposition_to_issuer","acquired":false,"shares":6363,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"On September 16, 2019, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Lundbeck, Lundbeck LLC and Purchaser.  On October 22, 2019 (the \"Effective Time\"), Purchaser merged with and into the Issuer pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Issuer being the surviving corporation and becoming a wholly-owned subsidiary of Lundbeck."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to this option, whether or not vested, were cancelled and converted into the right to receive both (i) a cash payment equal to (A) the excess, if any of (x) $18.00 over (y) the Exercise Price per share listed in Column 2 of Table II of this Form 4, multiplied by (B) the total number of shares listed in Column 5 of Table II of this Form 4, and (ii) one non-transferable contingent value right for each share subject to this option, which represents the contractual right to receive up to an additional $2.00 per share upon achievement of a milestone."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of January 1, 2014 (the \"2014 Vesting Commencement Date\") and 1/48th of the total number of shares each monthly anniversary of the 2014 Vesting Commencement Date thereafter for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the 2014 Vesting Commencement Date. The shares subject to this option are fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":6.325,"expiration_date":"2024-01-08","underlying":"Common Stock","underlying_shares":6363},"source":{"system":"sec-edgar","filing":"0001209191-19-053913","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1423824/000120919119053913/doc4.xml","form_type":"4"}},{"id":3388593,"issuer":{"id":154258,"kind":"organization","name":"ALDER BIOPHARMACEUTICALS INC","symbol":"ALDR"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-24T18:58:45.000Z","date":"2019-10-22","kind":"disposition_to_issuer","acquired":false,"shares":6363,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"On September 16, 2019, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Lundbeck, Lundbeck LLC and Purchaser.  On October 22, 2019 (the \"Effective Time\"), Purchaser merged with and into the Issuer pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Issuer being the surviving corporation and becoming a wholly-owned subsidiary of Lundbeck."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to this option, whether or not vested, were cancelled and converted into the right to receive both (i) a cash payment equal to (A) the excess, if any of (x) $18.00 over (y) the Exercise Price per share listed in Column 2 of Table II of this Form 4, multiplied by (B) the total number of shares listed in Column 5 of Table II of this Form 4, and (ii) one non-transferable contingent value right for each share subject to this option, which represents the contractual right to receive up to an additional $2.00 per share upon achievement of a milestone."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of January 1, 2013 (the \"2013 Vesting Commencement Date\") and 1/48th of the total number of shares each monthly anniversary of the 2013 Vesting Commencement Date thereafter for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the 2013 Vesting Commencement Date.  The shares subject to this option are fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":3.465,"expiration_date":"2023-03-12","underlying":"Common Stock","underlying_shares":6363},"source":{"system":"sec-edgar","filing":"0001209191-19-053913","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1423824/000120919119053913/doc4.xml","form_type":"4"}},{"id":3388592,"issuer":{"id":154258,"kind":"organization","name":"ALDER BIOPHARMACEUTICALS INC","symbol":"ALDR"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-24T18:58:45.000Z","date":"2019-10-22","kind":"disposition_to_issuer","acquired":false,"shares":6363,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"On September 16, 2019, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Lundbeck, Lundbeck LLC and Purchaser.  On October 22, 2019 (the \"Effective Time\"), Purchaser merged with and into the Issuer pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Issuer being the surviving corporation and becoming a wholly-owned subsidiary of Lundbeck."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to this option, whether or not vested, were cancelled and converted into the right to receive both (i) a cash payment equal to (A) the excess, if any of (x) $18.00 over (y) the Exercise Price per share listed in Column 2 of Table II of this Form 4, multiplied by (B) the total number of shares listed in Column 5 of Table II of this Form 4, and (ii) one non-transferable contingent value right for each share subject to this option, which represents the contractual right to receive up to an additional $2.00 per share upon achievement of a milestone."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of January 1, 2012 (the \"2012 Vesting Commencement Date\") and 1/48th of the total number of shares each monthly anniversary of the 2012 Vesting Commencement Date thereafter for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the 2012 Vesting Commencement Date. The shares subject to this option are fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":3.465,"expiration_date":"2023-03-12","underlying":"Common Stock","underlying_shares":6363},"source":{"system":"sec-edgar","filing":"0001209191-19-053913","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1423824/000120919119053913/doc4.xml","form_type":"4"}},{"id":3388591,"issuer":{"id":154258,"kind":"organization","name":"ALDER BIOPHARMACEUTICALS INC","symbol":"ALDR"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-24T18:58:45.000Z","date":"2019-10-22","kind":"disposition_to_issuer","acquired":false,"shares":12727,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"On September 16, 2019, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Lundbeck, Lundbeck LLC and Purchaser.  On October 22, 2019 (the \"Effective Time\"), Purchaser merged with and into the Issuer pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Issuer being the surviving corporation and becoming a wholly-owned subsidiary of Lundbeck."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of October 25, 2010 (the \"2010 Vesting Commencement Date\") and 1/48th of the total number of shares each monthly anniversary of the 2010 Vesting Commencement Date thereafter for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the 2010 Vesting Commencement Date.  The shares subject to this option are fully vested as of the date hereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to this option, whether or not vested, were cancelled and converted into the right to receive both (i) a cash payment equal to (A) the excess, if any of (x) $18.00 over (y) the Exercise Price per share listed in Column 2 of Table II of this Form 4, multiplied by (B) the total number of shares listed in Column 5 of Table II of this Form 4, and (ii) one non-transferable contingent value right for each share subject to this option, which represents the contractual right to receive up to an additional $2.00 per share upon achievement of a milestone."}],"balance_after":0,"derivative":{"exercise_price":3.96,"expiration_date":"2021-05-09","underlying":"Common Stock","underlying_shares":12727},"source":{"system":"sec-edgar","filing":"0001209191-19-053913","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1423824/000120919119053913/doc4.xml","form_type":"4"}},{"id":3388590,"issuer":{"id":154258,"kind":"organization","name":"ALDER BIOPHARMACEUTICALS INC","symbol":"ALDR"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-24T18:58:45.000Z","date":"2019-10-22","kind":"other","acquired":false,"shares":9628,"price":18,"value":173304.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On September 16, 2019, the Reporting Person entered into a Tender and Support (the \"Support Agreement\") with H. Lundbeck A/S (\"Lundbeck\"), Lundbeck LLC, Violet Acquisition Corp., a wholly owned subsidiary of Lundbeck (\"Purchaser\") and certain other securityholders of Issuer, pursuant to which the Reporting Person agreed to tender all shares of the Issuer's Common Stock, Class A-1 Convertible Preferred Stock or shares of Common Stock underlying stock options, as the case may be, held by Reporting Person to Purchaser (the \"Tender Offer\").  On October 22, 2019, Purchaser accepted the Tender Offer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person will also receive one non-transferable contingent value right for each share held, which will entitle them to receive up to an additional $2.00 per share upon achievement of a milestone."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-053913","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423824/000120919119053913/doc4.xml","form_type":"4"}},{"id":3476774,"issuer":{"id":4487,"kind":"organization","name":"Xencor Inc"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-27T23:41:43.000Z","date":"2019-06-26","kind":"grant","acquired":true,"shares":12731,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over one year beginning on the one-month anniversary of June 26, 2019, such that the total number of shares will be fully vested on June 26, 2020."}],"balance_after":12731,"derivative":{"exercise_price":39.08,"expiration_date":"2029-06-25","underlying":"Common Stock","underlying_shares":12731},"source":{"system":"sec-edgar","filing":"0001209191-19-039380","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1313936/000120919119039380/doc4.xml","form_type":"4"}},{"id":3510194,"issuer":{"id":154258,"kind":"organization","name":"ALDER BIOPHARMACEUTICALS INC","symbol":"ALDR"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-28T18:14:04.000Z","date":"2019-05-23","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall fully vest and become exercisable on the date of the 2020 Annual Meeting of the Stockholders of the Issuer, so long as the Reporting Person provides continuous service to the Issuer through such date."}],"balance_after":22500,"derivative":{"exercise_price":11.01,"expiration_date":"2029-05-22","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001209191-19-033074","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423824/000120919119033074/doc4.xml","form_type":"4"}},{"id":3882095,"issuer":{"id":4487,"kind":"organization","name":"Xencor Inc"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-27T21:59:34.000Z","date":"2018-06-26","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over one year beginning on the one-month anniversary of June 26, 2018, such that the total number of shares will be fully vested on June 26, 2019."}],"balance_after":7500,"derivative":{"exercise_price":38.93,"expiration_date":"2028-06-25","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-18-039697","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1313936/000120919118039697/doc4.xml","form_type":"4"}},{"id":3897814,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2018-06-12T21:58:30.000Z","date":"2018-06-08","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in four equal quarterly installments commencing on September 1, 2018."}],"balance_after":100000,"derivative":{"exercise_price":0.49,"expiration_date":"2028-06-08","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-18-016234","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000089924318016234/doc4.xml","form_type":"4"}},{"id":3916946,"issuer":{"id":154258,"kind":"organization","name":"ALDER BIOPHARMACEUTICALS INC","symbol":"ALDR"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-25T17:14:30.000Z","date":"2018-05-23","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall fully vest and become exercisable on the date of the 2019 Annual Meeting of the Stockholders of the Issuer, so long as the Reporting Person provides continuous service to the Issuer through such date."}],"balance_after":15000,"derivative":{"exercise_price":15.5,"expiration_date":"2028-05-22","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-18-033581","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423824/000120919118033581/doc4.xml","form_type":"4"}},{"id":4069680,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2018-02-10T01:06:05.000Z","date":"2018-02-07","kind":"grant","acquired":true,"shares":136563,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 7, 2018, the board of directors of CytoDyn Inc. approved an amendment to its director compensation program, providing for payment in stock options, in lieu of cash, of all unpaid director retainer fees for the four-quarter period ending February 28, 2018. The number of options awarded to each director was determined by applying a price of $0.31 per option, which was the fair value estimate of the option award as of the grant date, using the Black-Scholes option pricing model"}],"balance_after":136563,"derivative":{"exercise_price":0.56,"exercise_date":"2018-02-07","expiration_date":"2028-02-07","underlying":"Common Stock","underlying_shares":136563},"source":{"system":"sec-edgar","filing":"0000899243-18-003459","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000089924318003459/doc4.xml","form_type":"4"}},{"id":4272445,"issuer":{"id":4487,"kind":"organization","name":"Xencor Inc"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-26T20:32:12.000Z","date":"2017-06-22","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over one year beginning on the one-month anniversary of June 22, 2017, such that the total number of shares will be fully vested on June 22, 2018."}],"balance_after":7500,"derivative":{"exercise_price":22.2,"expiration_date":"2027-06-21","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-17-041839","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1313936/000120919117041839/doc4.xml","form_type":"4"}},{"id":4294822,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2017-06-05T20:45:24.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to stockholder approval, at the next annual meeting, of the increase in the number of shares of common stock authorized for issuance under the CytoDyn Inc. 2012 Equity Incentive Plan, as amended, the options will vest in four equal quarterly installments commencing on September 1, 2017."}],"balance_after":75000,"derivative":{"exercise_price":0.57,"expiration_date":"2027-06-01","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000899243-17-015352","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000089924317015352/doc4.xml","form_type":"4"}},{"id":4302890,"issuer":{"id":154258,"kind":"organization","name":"ALDER BIOPHARMACEUTICALS INC","symbol":"ALDR"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-26T18:15:34.000Z","date":"2017-05-24","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall fully vest and become exercisable on the date of the 2018 Annual Meeting of the Stockholders of the Issuer, so long as the Reporting Person provides continuous service to the Issuer through such date."}],"balance_after":15000,"derivative":{"exercise_price":16.9,"expiration_date":"2027-05-23","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-17-036008","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423824/000120919117036008/doc4.xml","form_type":"4"}},{"id":588377,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Respiratory Therapeutics"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2007-01-24T21:47:44.000Z","date":"2007-01-22","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest over a five year period beginning 1/22/2008, the first anniversary of the grant. The options continue to vest in quarterly installments over the next four years, ending on 1/22/2012."}],"balance_after":20000,"derivative":{"exercise_price":65.58,"expiration_date":"2017-01-22","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001179110-07-001860","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007001860/edgar.xml","form_type":"4"}},{"id":598877,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Respiratory Therapeutics"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-09-12T23:32:09.000Z","date":"2006-09-11","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options will vest 20% on September 11, 2007, the first anniversay date of the grant.  The balance will vest 5% every three months thereafter until fully vested on September 11, 2011."}],"balance_after":70000,"derivative":{"exercise_price":63.69,"expiration_date":"2016-09-11","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001179110-06-018343","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006018343/edgar.xml","form_type":"4"}},{"id":598876,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17295,"kind":"person","name":"Montgomery Alan Bruce","position":1,"cik":"0001313936","reported_name":"Montgomery Alan Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Respiratory Therapeutics"}}],"security":"Common Stock","published_at":"2006-09-12T23:32:09.000Z","date":"2006-09-11","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares are issued as a restricted stock award scheduled to vest in three equal installments contingent upon the achievement of certain pre-determined milestones."}],"balance_after":14280,"source":{"system":"sec-edgar","filing":"0001179110-06-018343","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006018343/edgar.xml","form_type":"4"}}]}